Metabolic reprogramming induces resistance to anti-NOTCH1 therapies in T cell acute lymphoblastic leukemia
Nature Medicine2015Vol. 21(10), pp. 1182–1189
Citations Over TimeTop 10% of 2015 papers
Daniel Herranz, Alberto Ambesi‐Impiombato, Jessica Sudderth, Marta Sánchez-Martín, Laura Belver, Valeria Tosello, Luyao Xu, Agnieszka A. Wendorff, Mireia Castillo-Martín, J. Erika Haydu, Javier Márquez, José M. Matés, Andrew L. Kung, Stephen Rayport, Carlos Cordon‐Cardo, Ralph J. DeBerardinis, Adolfo A. Ferrando
Related Papers
- → PTEN expression is reduced in a subset of sporadic thyroid carcinomas: evidence that PTEN-growth suppressing activity in thyroid cancer cells is mediated by p27kip1(2000)145 cited
- → Roles of PTEN inactivation and PD-1/PD-L1 activation in esophageal squamous cell carcinoma(2022)9 cited
- → Inhibition of PRL2 Upregulates PTEN and Attenuates Tumor Growth in Tp53 -deficient Sarcoma and Lymphoma Mouse Models(2023)4 cited
- → Genetic profile, PTEN mutation and therapeutic role of PTEN in glioblastomas(2002)31 cited
- → RETRACTED ARTICLE: Inhibited MicroRNA-301 Restrains Angiogenesis and Cell Growth in Esophageal Squamous Cell Carcinoma by Elevating PTEN(2021)5 cited